Binary probe and clamp composition
View Patent ↗Binary probe and clamp compositions conduct methods for target hybridization detection. Where the probe is a substrate for exonuclease cleavage, the composition provides quantitation and detection of PCR products, by real-time and end-point measurements. Where the probe is an amplification primer, the composition provides an improved method for labelling and detection of PCR products. Probes and clamps may be labelled with fluorescent dyes, quenchers, hybridization-stabilizing moieties, chemiluminescent dyes, and affinity ligands. Clamps may be nucleic acid analogs, such as 2-aminoethylglycine PNA.
1. A binary-probe composition for hybridizing to a target polynucleotide sequence comprising:
a probe comprising a target-specific portion and a clamp-specific portion wherein the target-specific portion is capable of sequence-specific binding to a target polynucleotide sequence; and
a clamp comprising two probe-specific portions and one or more labels wherein the two probe-specific portions of the clamp are capable of sequence-specific binding to the clamp-specific portion of the probe, the two probe-specific portions of the clamp are incapable of sequence-specific binding to the target polynucleotide, and the clamp is non-extendable by a polymerase;
wherein the binary-probe composition is formed by hybridizing the clamp-specific portion of the probe to the two probe-specific portions of the clamp by sequence-specific binding to form a triplex structure.
2. The binary-probe composition of claim 1 wherein the probe comprises 6 to 100 nucleotides.
3. The binary-probe composition of claim 1 wherein the clamp-specific portion of the probe comprises purine nucleotides.
4. The binary-probe composition of claim 1 wherein the probe-specific portion of the clamp comprises pyrimidine nucleobase analogs.
5. The binary-probe composition of claim 1 wherein the clamp comprises 6 to 50 nucleotide analogs.
6. The binary-probe composition of claim 1 wherein the clamp sequence comprises (CAG) n where n=1–10.
7. The binary-probe composition of claim 1 wherein the clamp sequences include (TCC) n and nucleic acid analogs which bind the probe sequence (GGA) n where n=1–10.
8. The binary-probe composition of claim 1 wherein the clamp or the probe is a nucleic acid analog selected from nucleobase analogs, sugar analogs, and internucleotide analogs.
9. The binary-probe composition of claim 8 wherein the nucleobase analogs are selected from C-5-alkyl pyrimidine, 2,6-diaminopurine, 2-thiopyrimidine, C-5-propyne pyrimidine, 7-deazapurine, isocytidine, pseudo-isocytidine, isoguanosine, 4(3H)-pyrimidone, hypoxanthine, 8-oxopurine, and universal base.
10. The binary-probe composition of claim 8 wherein the sugar analogs are selected from 2′-O-alkyl-ribonucleotides, 2′-O-methyl-ribonucleotides, 2′-O-allyl-ribonucleotides, 2′-allyl ribonucleotides, 2′-halo-ribonucleotides, 2′-O-methoxyethyl-ribonucleotides, 2′-branching group-ribonucleotides, 2′-O-branching group-ribonucleotides, 4′-α-anomeric nucleotides, and 1′-α-anomeric nucleotides.
11. The binary-probe composition of claim 8 wherein the internucleotide analogs are selected from 2-aminoethylglycine, 2′-5′-linkage, inverted 3′-3′ linkage, inverted 5′-5′ linkage, phosphorothioate, methyl phosphonate, non-bridging N-substituted phosphoramidate, alkylated phosphotriester branched structure, and 3′-N-phosphoramidate.
12. The binary-probe composition of claim 1 wherein the clamp comprises a non base-pairing, non-nucleosidic linker.
13. The binary-probe composition of claim 1 wherein the clamp comprises one or more 2-aminoethylglycine monomer units.
14. The binary-probe composition of claim 1 wherein the clamp has one or more labels attached at sites consisting of a terminus, a nucleobase, an internucleotide linkage, a sugar, an amino group, a sulfide group, and a carboxyl group.
15. The binary-probe composition of claim 1 wherein the probe comprises one or more labels.
16. The binary-probe composition of claim 15 wherein the label is attached at sites selected from a 5′ terminus, a 3′ terminus, a nucleobase, an internucleotide linkage, and a sugar.
17. The binary-probe composition of claim 1 or 15 wherein the clamp and probe labels are selected from hybridization-stabilizing moieties, fluorescent dyes, fluorescence quenchers, chemiluminescent dyes, amino acids, and affinity ligands.
18. The binary-probe composition of claim 17 wherein the hybridization-stabilizing moieties are selected from minor groove binders, intercalators, and cross-linking functional groups.
19. The binary-probe composition of claim 18 wherein the minor groove binders are selected from the group consisting of Hoechst 33258, CDPI 1-3 , MGB1, netropsin, and distamycin.
20. The binary-probe composition of claim 17 wherein the fluorescent dyes are selected from 6-carboxyfluorescein, 2′,7′,1,4-tetrachloro-5-carboxyfluorescein, 2′,7′,1,4-tetrachloro-6-carboxyfluorescein, 2′,4′,5′,7′,1,4-hexachloro-5-carboxyfluorescein, 2′,4′, 5′,7′,1,4-hexachloro-6-carboxyfluorescein, 2′,7′-dimethoxy-4′,5′-dichloro-5-carboxyfluorescein, 2′,7′-dimethoxy-4′,5′-dichloro-6-carboxyfluorescein, tetramethyl-5-carboxy-rhodamine, tetramethyl-6-carboxy-rhodamine, tetrapropano-5-carboxyrhodamine, tetra-propano-6-carboxyrhodamine, 2′-chloro-7′-phenyl-1,4-dichloro-5-carboxyfluorescein, 2′-chloro-7′-phenyl-1,4-dichloro-6-carboxy-fluorescein, 2′-chloro-5′-fluoro-7′,8′-fused-phenyl-1,4-dichloro-5-carboxyfluorescein, 2′-chloro-5′-fluoro-7′,8′-fused-phenyl-1,4-dichloro-6-carboxyfluorescein, 4,7-dichlorofluorescein, 4,7-dichlororhodamine, and cyanines.
21. The binary-probe composition of claim 17 wherein the fluorescence quenchers are selected from N,N,N′N′-tetramethyl-5-carboxyrhodamine, N,N,N′N′-tetramethyl-6-carboxy-rhodamine, nitrothioazole blue, tetrapropandiyl-5-carboxy-rhodamine, tetrapropandiyl-6-carboxyrhodamine, DABCYL, DABSYL, malachite green, and cyanines.
22. The binary-probe composition of claim 17 wherein the chemiluminescent dyes are selected from chemiluminescent precursors having the structure
where R 1 is hydrogen or halogen; R 2 is phosphate, galactoside, glucoside, glucuronide, trialkylsilyloxy, acyloxy, or hydrogen; R 3 is methyl, ethyl, lower alkyl; and L is a linker.
23. The binary-probe composition affinity of claim 17 wherein the affinity ligands are selected from biotin, dinitrophenyl, digoxigenin, cholesterol, polyethyleneoxy, and peptides.
24. A binary-primer composition for hybridizing to a target polynucleotide sequence comprising:
a primer comprising a target-specific portion and a clamp-specific portion wherein the target-specific portion is capable of sequence-specific binding to a target polynucleotide sequence, and the primer is extendable by a polymerase at the 3′-end of the target-specific portion; and
a clamp comprising two primer-specific portions and one or more labels wherein the two primer-specific portion are capable of sequence-specific binding to the clamp-specific portion of the primer, the two primer-specific portions of the clamp are incapable of sequence-specific binding to the target polynucleotide, and the clamp is non-extendable by a polymerase;
wherein the binary-primer composition is formed by hybridizing the clamp-specific portion of the primer to the two primer-specific portions of the clamp by sequence-specific binding to form a triplex structure.
25. The binary-primer composition of claim 24 wherein the primer comprises 6 to 100 nucleotides.
26. The binary-primer composition of claim 24 wherein the clamp-specific portion of the primer comprises purine nucleotides.
27. The binary-primer composition of claim 24 wherein the primer specific portion of the clamp comprises pyrimidine nucleobase analogs.
28. The binary-primer composition of claim 24 wherein the clamp comprises 6 to 50 nucleotide analogs.
29. The binary-primer composition of claim 24 wherein the clamp sequence comprises (CAG) n where n=1–10.
30. The binary-primer composition of claim 24 wherein the clamp sequences include (TCC) n and nucleic acid analogs which bind the primer sequence (GGA) n where n=1–10.
31. The binary-primer composition of claim 24 wherein the clamp or the primer is a nucleic acid analog selected from nucleobase analogs, sugar analogs, and internucleotide analogs.
32. The binary-primer composition of claim 31 wherein the nucleobase analogs are selected from C-5-alkyl pyrimidine, 2,6-diaminopurine, 2-thiopyrimidine, C-5-propyne pyrimidine, 7-deazapurine, isocytidine, pseudo-isocytidine, isoguanosine, 4(3H)-pyrimidone, hypoxanthine, 8-oxopurine, and universal base.
33. The binary-primer composition of claim 31 wherein the sugar analogs are selected from 2′-O-alkyl-ribonucleotides, 2′-O-methyl-ribonucleotides, 2′-O-allyl-ribonucleotides, 2′-allyl ribonucleotides, 2′-halo-ribonucleotides, 2′-O-methoxyethyl-ribonucleotides, 2′-branching group-ribonucleotides, 2′-O-branching group-ribonucleotides, 4′-α-anomeric nucleotides, and 1′-α-anomeric nucleotides.
34. The binary-primer composition of claim 31 wherein the internucleotide analogs are selected from 2-aminoethylglycine, 2′-5′-linkage, inverted 3′-3′ linkage, inverted 5′-5′ linkage, phosphorothioate, methyl phosphonate, non-bridging N-substituted phosphoramidate, alkylated phosphotriester branched structure, and 3′-N-phosphoramidate.
35. The binary-primer composition of claim 24 wherein the clamp comprises a non base-pairing, non-nucleosidic linker.
36. The binary-primer composition of claim 24 wherein the clamp comprises one or more 2-aminoethylglycine monomer units.
37. The binary-primer composition of claim 24 wherein the clamp has one or more labels attached at sites consisting of a terminus, a nucleobase, an internucleotide linkage, a sugar, an amino group, a sulfide group, and a carboxyl group.
38. The binary-primer composition of claim 24 wherein the primer comprises one or more labels.
39. The binary-primer composition of claim 38 wherein the label is attached at sites selected from a 5′ terminus, a 3′ terminus, a nucleobase, an internucleotide linkage, and a sugar.
40. The binary-primer composition of claims 24 and 38 wherein the clamp and primer labels are selected from hybridization-stabilizing moieties, fluorescent dyes, fluorescence quenchers, chemiluminescent dyes, amino acids, and affinity ligands.
41. The binary-primer composition of claim 40 wherein the hybridization-stabilizing moieties are selected from minor groove binders, intercalators, and cross-linking functional groups.
42. The binary-primer composition of claim 41 wherein the minor groove binders are selected from the group consisting of Hoechst 33258, CDPI 1-3 , MGB1, netropsin, and distamycin.
43. The binary-primer composition of claim 40 wherein the fluorescent dyes are selected from 6-carboxyfluorescein, 2′,7′,1,4-tetrachloro-5-carboxyfluorescein, 2′, 7′,1,4-tetrachloro-6-carboxyfluorescein, 2′,4′,5′,7′,1,4-hexachloro-5-carboxyfluorescein, 2′,4′, 5′,7′,1,4-hexachloro-6-carboxyfluorescein, 2′,7′-dimethoxy-4′,5′-dichloro-5-carboxyfluorescein, 2′,7′-dimethoxy-4′,5′-dichloro-6-carboxyfluorescein, tetramethyl-5-carboxyrhodamine, tetramethyl-6-carboxy-rhodamine, tetrapropano-5-carboxyrhodamine, tetra-propano-6-carboxyrhodamine, 2′-chloro-7′-phenyl-1,4-dichloro-5-carboxyfluorescein, 2′-chloro-7′-phenyl-1,4-dichloro-6-carboxy-fluorescein, 2′-chloro-5′-fluoro-7′,8′-fused-phenyl-1,4-dichloro-5-carboxyfluorescein, 2′-chloro-5′-fluoro-7′,8′-fused-phenyl-1,4-dichloro-6-carboxyfluorescein, 4,7-dichlorofluorescein, 4,7-dichloro-rhodamine, and cyanines.
44. The binary-primer composition of claim 40 wherein the fluorescence quenchers are selected from TAMRA, NTB, ROX, DABCYL, DABSYL, malachite green, and cyanines.
45. The binary-primer composition of claim 40 wherein the chemiluminescent dyes are selected from chemiluminescent precursors having the structure
where R 1 is hydrogen or halogen; R 2 is phosphate, galactoside, glucoside, glucuronide, trialkylsilyloxy, acyloxy, or hydrogen; R 3 is methyl, ethyl, lower alkyl; and L is a linker.
46. The binary-primer composition of claim 40 wherein the affinity ligands are selected from biotin, dinitrophenyl, digoxigenin, cholesterol, polyethyleneoxy, and peptides.